Related Experiment Video

Updated: May 15, 2026

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
07:54

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Published on: December 21, 2019

PSMA-PET Total Tumor Volume Response: Ready for Prime Time or a Work in Progress?

Joseph R Osborne1, Tobechukwu Joseph Okobi2, Valentina Marulanda-Corzo3

  • 1Division of molecular imaging and therapeutics, Department of Radiology, Weill Cornell Medicine, NewYork-Presbyterian, New York, NY, USA; Meyer Cancer Center, New York, NY, USA.

European Urology
|May 13, 2026
PubMed
Summary

No abstract available in PubMed .

Keywords:
(68)Ga-PSMA-11 PET/CTEnzalutamidePSMA-TTVTargeted radionuclide therapy[(177)Lu] Lu-PSMA-617

More Related Videos

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy (PRRT): 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
09:49

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy (PRRT): 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

Published on: April 24, 2020

Preclinical Positron Emission Tomography with Body Conforming Animal Molds for Cloud-Based Automated Image Analysis in Mice
07:45

Preclinical Positron Emission Tomography with Body Conforming Animal Molds for Cloud-Based Automated Image Analysis in Mice

Published on: October 25, 2024

Related Experiment Videos

Last Updated: May 15, 2026

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
07:54

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Published on: December 21, 2019

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy (PRRT): 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
09:49

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy (PRRT): 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

Published on: April 24, 2020

Preclinical Positron Emission Tomography with Body Conforming Animal Molds for Cloud-Based Automated Image Analysis in Mice
07:45

Preclinical Positron Emission Tomography with Body Conforming Animal Molds for Cloud-Based Automated Image Analysis in Mice

Published on: October 25, 2024

Related Concept Videos

Positron Emission Tomography01:29

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...

Articles linked to this work by shared authors, journal, and citation graph.

How Will PSMAddition Impact the Management of Prostate Cancer?

European urology focus·2026

Top advances of the year: Radiopharmaceutical therapy for prostate cancer.

Cancer·2026

Temporal Trends in the Frequency of Concomitant Cancer and Cerebrovascular Disease Diagnoses in the United States.

Neurology. Clinical practice·2026

PET-guided Assessment of Amyloid Clearance and Outcomes in a Real-World Cohort of Patients with Alzheimer Disease undergoing Anti-Amyloid Therapy.

AJNR. American journal of neuroradiology·2026

Cross-Platform Concordance of Quantitative Amyloid PET Z-Scores in a Real-World Clinical Cohort of Patients with Cognitive Impairment and Suspected Alzheimer Disease.

AJNR. American journal of neuroradiology·2026

Stereotactic Body Radiation Therapy (SBRT)-Induced 68Ga-PSMA PET Bone Flare.

Clinical nuclear medicine·2026

EAU Guidelines on Nonmuscle-invasive Bladder Cancer (TaT1 and CIS) - A Summary of the 2026 Guidelines Update.

European urology·2026

EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer. Part II-2026 Update: Treatment of Relapsing and Metastatic Prostate Cancer.

European urology·2026

EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer-2026 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent.

European urology·2026

European Association of Urology Guidelines on Urological Infections: Summary of the 2026 Guidelines.

European urology·2026

European Association of Urology Guidelines on Neuro-urology: Summary of the 2026 Update.

European urology·2026

Confirmation of Prostate-specific Antigen (PSA) Values Improves Prostate Cancer Screening in Early Middle-Aged Men - Data from the PROBASE Trial.

European urology·2026

Erratum: Defining the optimal imaging time point for fluorescence-lifetime-based tumor identification using the non-targeting near-infrared dye indocyanine green and post-processed high-dynamic-range images: errata.

Biomedical optics express·2026

Low-Dose Radiotherapy for Benign Achillodynia: A Single Center Experience With Prospective Follow-Up.

Cureus·2026

Microfluidic Isolation of Aptamers for Intracellular Measurement of Radio-Responsive Proteins.

Radiation (Multidisciplinary Digital Publishing Institute)·2026

Microenvironmental remodeling in FLASH radiotherapy.

Frontiers in cell and developmental biology·2026

Open Boari Flap Ureteroneocystostomy in a Radiated Pelvis: A Durable Solution for Complex Distal Ureteric Strictures.

Annals of African medicine·2026

Definitive carbon ion radiotherapy for thoracic bone and soft tissue sarcoma.

BMC cancer·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us